Navigation Links
Boca Pharmacal Receives FDA Approval on Glycopyrrolate Tablets
Date:10/21/2011

CORAL SPRINGS, Fla., Oct. 21, 2011 /PRNewswire/ -- Boca Pharmacal, Inc., today announced that it has received approval from the FDA of its Abbreviated New Drug Application (ANDA) for Glycopyrrolate Tablets USP, 1 mg and 2 mg, the generic version of Robinul Tablets, 1 mg and Robinul Forte Tablets, 2 mg, distributed by Shionogi Pharma, Inc. Glycopyrrolate tablets are intended for use as adjunctive therapy in the treatment of peptic ulcers.

"We're up to our third approval this year," said Robert Edwards, CEO of Boca Pharmacal.  "Each approval – including Glycopyrrolate Tablets – has been consistent with our mission to pursue and provide products to the marketplace that are important to our customers, but may be overlooked by some of the huge multinationals. We're continuing to file new ANDAs, and will keep doing so in our ongoing effort to provide the generic products our customers – and their patients – need."

Boca Pharmacal, Inc.

Since its beginnings in 1998, Boca Pharmacal's mission has been to offer niche items that were overlooked by some of the larger generic companies as affordable alternatives to brand-named products.

Using multiple facilities across the globe, Boca Pharmacal has a broad reach and a reliable vertical structure that allows them to develop products that include tablets and capsules, semi-solids, solutions, and suspensions. They continue to invest in research and development to make sure they're providing their clients with a wide variety of offerings. The Boca Pharmacal product line is marketed to chains, wholesalers, distributors, managed markets and government agencies.  Boca Pharmacal is located at 3550 NW 126th Avenue, Coral Springs, Florida, 33065. For more information visit www.bocapharmacal.com.CONTACT:

Jennifer MouraBoca Pharmacal3550 NW 126th AveCoral Springs, FL 33065Phone: (954) 346-8810Email:

SOURCE Boca Pharmacal, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Mission Pharmacal Launches CitraNatal(R) Assure Prescription Prenatal Vitamin
2. Mission Pharmacal Launches New Vitamin B6-Rich Prescription Prenatal Vitamin, CitraNatal(R) B-Calm
3. Nautilus Neurosciences and Mission Pharmacal Announce Exclusive Co-Promotion Agreement for CAMBIA™ (diclofenac potassium for oral solution) for the Acute Treatment of Migraine to the Womens Health Market
4. Boca Pharmacal Receives FDA Approval for Hydrocodone Bitartrate and Acetaminophen Tablets
5. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
6. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
7. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
8. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
9. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
10. CryoCor Receives FDA Approval for Right Atrial Flutter
11. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Cryoport, Inc. (OTCBB: CYRX) today announced financial results for ... Recent Operating Highlights , Achieved 92% ... period ended June 30, 2014 compared to the prior ... expand Cryoport,s global reach using the ,powered by Cryoport ... an immunotherapy and vaccine development services company, to support ...
(Date:7/31/2014)... 31, 2014 Orexigen® Therapeutics, Inc. (Nasdaq: ... second quarter 2014, on Thursday, August 7, 2014 before ... live webcast and conference call at 8:00 a.m. Eastern ... will host the call and webcast to discuss financial ... be accessed by calling (800) 708-4540 (domestic) or (847) ...
(Date:7/31/2014)... N.J. , July 31, 2014  Celsion Corporation ... Company will host a conference call to discuss its ... on Thursday, August 7, 2014. To participate in the ... America ) or 1-785-830-1924 (International/Toll) and ask for ... Code: 8283269) to register ten minutes before the call ...
Breaking Medicine Technology:Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 2Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 3Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 4Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 5Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 6Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 7Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 8Orexigen Therapeutics to Host Second Quarter 2014 Financial Results Conference Call and Webcast 2Celsion Corporation to Hold Second Quarter 2014 Financial Results 2
... Clinic,s Top 10 Medical Innovations for 2010 list features a ... developed to treat everything from deafness and Parkinson,s disease to ... devices and therapies was selected by a panel of Cleveland ... Cleveland Clinic,s 2009 Medical Innovation Summit , which ...
... Medco Health Solutions, Inc. (NYSE: MHS ) is ... getting the most value out of their Medicare prescription drug ... different plan options - Choice , Access , ... access to a vast array of medications, pharmacy locations, and ...
Cached Medicine Technology:Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2010 2Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2010 3Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2010 4Medco's 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs 2Medco's 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs 3Medco's 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs 4
(Date:7/31/2014)... of adults with ADHD improve when their ADHD ... College of Medicine researchers., At least 25 percent ... a parent with ADHD. , "Parents with ADHD ... parenting techniques, including inconsistent disciplinary practices, making ineffectual ... Waxmonsky, associate professor of psychiatry. "Having a parent ...
(Date:7/31/2014)... 2014 Jacuzzi Luxury Bath, ... has launched a new and improved website to meet ... The Jacuzzi Luxury Bath website has been redesigned to ... and quality represented by the company’s products. The design ... and inspirational bathroom applications. “The site reflects our Jacuzzi® ...
(Date:7/31/2014)... The “Nucleic Acid Isolation and Purification ... bead based), Consumables & Instruments, by Application (Plasmid ... users - Global Forecasts to 2018” provides a ... opportunities, current market trends, and strategies impacting the ... with the estimates and forecasts of the revenue ...
(Date:7/31/2014)... Long associated with enabling the proliferation of ... by Heat-Shock Factor 1 (HSF1) can also turn ... support malignant progression and metastasis. , The finding, ... the journal Cell , lends new insights ... diagnosis, prognosis, and management of cancer patients. ...
(Date:7/31/2014)... According to a new market report ... Market - Global Forecast, Market Share, Size, Growth and ... fixation devices market is estimated at USD 6.1 billion ... CAGR of 7.2% from 2014 to 2019, to reach ... Globally, the orthopedic trauma fixation devices market is witnessing ...
Breaking Medicine News(10 mins):Health News:Parenting skills improve in ADHD parents with medication 2Health News:Jacuzzi Luxury Bath Launches New and Improved Website 2Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 4Health News:Master HSF supports reprogramming of normal cells to enable tumor growth and metastasi 2Health News:Master HSF supports reprogramming of normal cells to enable tumor growth and metastasi 3Health News:Orthopedic Trauma Fixation Devices Market: Global Forecast, Share, Size, Growth and Industry Analysis 2014 - 2020 2Health News:Orthopedic Trauma Fixation Devices Market: Global Forecast, Share, Size, Growth and Industry Analysis 2014 - 2020 3
... Allows Pharmaceutical Brand Managers to Build Patient-Flow Models ... Decision Resources, one of the world,s leading ... healthcare issues, finds that use of Novartis, Diovan ... Cozaar is influenced by physician perception that the ...
... Pharmaceutical Research and Manufacturers of America (PhRMA) President and ... a new healthcare reform coalition:"PhRMA echoes the sentiment shared ... is critical for all Americans to have access to ... central goal in mind, we are working with a ...
... stroke specialists, especially in rural or other underserved areas; ... a "mini" or "warning" stroke, should be treated with ... two separate scientific statements and a policy statement published ... Association . , Telemedicine Statement Highlights: , ...
... May 11 David Cornfield, MD, the chief ... Lucile Packard Children,s Hospital at Stanford, has been ... (SPR).(Photo: http://www.newscom.com/cgi-bin/prnh/20090511/SF14213 )Beginning this month, Cornfield ... pediatricians for a one-year term. "It,s a great ...
... WASHINGTON, May 11 President Obama and U.S. Senate ... protection laws as suggested by health insurers last week, ... said Consumer Watchdog in a letter to the president ... every state over the last 10 years were made ...
... run on behalf of 1.275 million Americans living with spinal ... Dana Reeve Foundation today announced Matthew Reeve, son of Christopher ... Reeve Foundation, will run the 2009 ING New York City ... inspired to compete on behalf of the 1.275 million Americans ...
Cached Medicine News:Health News:More Patients Receive Diovan As A First- Or Second-Line Therapy Compared With Cozaar or Avapro 2Health News:More Patients Receive Diovan As A First- Or Second-Line Therapy Compared With Cozaar or Avapro 3Health News:PhRMA Statement on Healthcare Reform Coalition 2Health News:PhRMA Statement on Healthcare Reform Coalition 3Health News:PhRMA Statement on Healthcare Reform Coalition 4Health News:Videoconferencing can increase patient access to stroke specialists 2Health News:Videoconferencing can increase patient access to stroke specialists 3Health News:Packard/Stanford Physician to Lead Society for Pediatric Research 2Health News:President Obama, Sens. Kennedy & Baucus: Don't Buy Insurer 'Compromise' for Bush-era Plan to Gut State Consumer Protection Laws 2Health News:President Obama, Sens. Kennedy & Baucus: Don't Buy Insurer 'Compromise' for Bush-era Plan to Gut State Consumer Protection Laws 3Health News:Matthew Reeve to Run 2009 ING New York City Marathon for Team Reeve 2Health News:Matthew Reeve to Run 2009 ING New York City Marathon for Team Reeve 3
... Package is a solid solution ... The package includes the Vibratome ... mounting blocks, v-block adapter, specimen ... rotating stage assembly for ease ...
... Professional Package is the best ... laboratory. The package includes the ... additional mounting blocks, v-block adapter, ... a sapphire blade for the ...
... Vibratome 3000 Plus Sectioning System provides a ... animal, or plant tissues. The 3000 ... sectioning without freezing or embedding. The ... the destruction of enzyme activities, and other ...
... System provides a versatile means of sectioning ... The 1500 employs a vibrating blade ... embedding. The creation of artifacts, the ... activities, and other deleterious effect inherent in ...
Medicine Products: